1
|
Abdallah W, Spaggiari E, Brisset S, Dard R, Attié Bitach T, Bault JP, Quibel T. Prenatal Diagnosis of Primrose Syndrome. JOURNAL OF ULTRASOUND IN MEDICINE : OFFICIAL JOURNAL OF THE AMERICAN INSTITUTE OF ULTRASOUND IN MEDICINE 2024; 43:411-414. [PMID: 37929614 DOI: 10.1002/jum.16354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 09/26/2023] [Indexed: 11/07/2023]
Abstract
Primrose syndrome is a very rare congenital malformation. Symptoms of this disorder may appear during childhood, but the diagnosis is identified in adulthood in the majority of cases. The prenatal diagnosis of Primrose syndrome is not developed in the literature. We present herein a case series of 3 cases with characteristic sonographic features. A dysmorphic metopic suture, downslanting palpebral fissures, a wide forehead, and agenesis of corpus callosum are the main signs. A missense mutation in ZBTB20 identified in whole exome sequencing can confirm the prenatal diagnosis of Primrose syndrome.
Collapse
Affiliation(s)
- Wael Abdallah
- Department of Obstetrics and Maternal-Fetal Medicine, CHI Poissy St Germain-en-Laye, Poissy, France
| | - Emmanuel Spaggiari
- Department of Obstetrics and Maternal-Fetal Medicine, Necker-Enfants Malades Hospital, Paris, France
| | - Sophie Brisset
- Service de génétique, Centre hospitalier de Versailles, Paris, France
| | - Rodolphe Dard
- Genetics Department, CHI Poissy St Germain-en-Laye, Poissy, France
| | - Tania Attié Bitach
- Médecine génomique des Maladies rares, Necker-Enfants Malades Hospital, AP-HP, Paris, France
| | - Jean Philippe Bault
- Department of Obstetrics and Maternal-Fetal Medicine, CHI Poissy St Germain-en-Laye, Poissy, France
| | - Thibault Quibel
- Department of Obstetrics and Maternal-Fetal Medicine, CHI Poissy St Germain-en-Laye, Poissy, France
| |
Collapse
|
2
|
Li J, Zhang C, Tian X, Zhou B, Chen X, Wang Y, Hao S, Hui L, Meng Z. Novel de novo mutation in ZBTB20 in a Chinese Primrose syndrome family and a review of the literature. Mol Genet Genomic Med 2024; 12:e2304. [PMID: 38087819 PMCID: PMC10767601 DOI: 10.1002/mgg3.2304] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 09/01/2023] [Accepted: 10/13/2023] [Indexed: 01/07/2024] Open
Abstract
BACKGROUND Primrose syndrome is an autosomal dominant disorder characterized by craniofacial dysmorphism, mental retardation, developmental delay, progressive muscle atrophy and calcification of the earlobe due to a mutation in the ZBTB20. METHOD We reported a case of a Chinese boy with clinical symptoms resembling Primrose Syndrome, and performed genetic etiology analysis of the proband's family through Trio whole exome sequencing. RESULT A novel missense variant c.1927T>A(p.F643I) in exon 14 of the ZBTB20 (NM_001348803) was identified in the proband. This is the first report case of primrose syndrome in China, and our case extends the variant spectrum of ZBTB20 and further strengthens the understanding of primrose syndrome. CONCLUSION However, there are no formal clinical guidelines for the management of this disease, and research on treatment and prognosis remains a challenge and focus in future.
Collapse
Affiliation(s)
- Jiayi Li
- First School of Clinical MedicalGansu University of Chinese MedicineLanzhouChina
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Chuan Zhang
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Xinyuan Tian
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Bingbo Zhou
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Xue Chen
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Yupei Wang
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Shengju Hao
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
| | - Ling Hui
- First School of Clinical MedicalGansu University of Chinese MedicineLanzhouChina
- Gansu Province Maternity and Child Health Care Hospital, Medical Genetics CenterGansu Provincial Clinical Research Center for Birth Defects and Rare DiseasesLanzhouChina
- Department of ObstetricsGansu Province Maternity and Child Health Care HospitalLanzhouChina
| | - Zhaoyan Meng
- First School of Clinical MedicalGansu University of Chinese MedicineLanzhouChina
- Department of ObstetricsGansu Province Maternity and Child Health Care HospitalLanzhouChina
| |
Collapse
|
3
|
Melis D, Carvalho D, Barbaro-Dieber T, Espay AJ, Gambello MJ, Gener B, Gerkes E, Hitzert MM, Hove HB, Jansen S, Jira PE, Lachlan K, Menke LA, Narayanan V, Ortiz D, Overwater E, Posmyk R, Ramsey K, Rossi A, Sandoval RL, Stumpel C, Stuurman KE, Cordeddu V, Turnpenny P, Strisciuglio P, Tartaglia M, Unger S, Waters T, Turnbull C, Hennekam RC. Primrose syndrome: Characterization of the phenotype in 42 patients. Clin Genet 2020; 97:890-901. [PMID: 32266967 PMCID: PMC7384157 DOI: 10.1111/cge.13749] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 03/20/2020] [Accepted: 03/24/2020] [Indexed: 12/13/2022]
Abstract
Primrose syndrome (PS; MIM# 259050) is characterized by intellectual disability (ID), macrocephaly, unusual facial features (frontal bossing, deeply set eyes, down‐slanting palpebral fissures), calcified external ears, sparse body hair and distal muscle wasting. The syndrome is caused by de novo heterozygous missense variants in ZBTB20. Most of the 29 published patients are adults as characteristics appear more recognizable with age. We present 13 hitherto unpublished individuals and summarize the clinical and molecular findings in all 42 patients. Several signs and symptoms of PS develop during childhood, but the cardinal features, such as calcification of the external ears, cystic bone lesions, muscle wasting, and contractures typically develop between 10 and 16 years of age. Biochemically, anemia and increased alpha‐fetoprotein levels are often present. Two adult males with PS developed a testicular tumor. Although PS should be regarded as a progressive entity, there are no indications that cognition becomes more impaired with age. No obvious genotype‐phenotype correlation is present. A subgroup of patients with ZBTB20 variants may be associated with mild, nonspecific ID. Metabolic investigations suggest a disturbed mitochondrial fatty acid oxidation. We suggest a regular surveillance in all adult males with PS until it is clear whether or not there is a truly elevated risk of testicular cancer.
Collapse
Affiliation(s)
- Daniela Melis
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Salerno, Italy.,Department of Translational Medical Science, Federico II University, Naples, Italy
| | - Daniel Carvalho
- Medical Genetic Unit, SARAH Network of Rehabilitation Hospitals, Brasilia, Brazil
| | | | - Alberto J Espay
- Department of Neurology, University of Cincinnati, Gardner Family Center for Parkinson's Disease and Movement Disorders, Cincinnati, Ohio, USA
| | - Michael J Gambello
- Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA
| | - Blanca Gener
- Department of Genetics, BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Bizkaia, Spain
| | - Erica Gerkes
- Department of Genetics, University of Groningen, UMC Groningen, Groningen, The Netherlands
| | - Marrit M Hitzert
- Department of Genetics, University of Groningen, UMC Groningen, Groningen, The Netherlands
| | - Hanne B Hove
- Department of Pediatrics, Division of Rare Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | - Sandra Jansen
- Department of Human Genetics, Radboud UMC, Nijmegen, The Netherlands
| | - Petr E Jira
- Department of Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands
| | - Katherine Lachlan
- Wessex Clinical Genetics Service, University Hospitals of Southampton NHS Trust, Southampton, UK
| | - Leonie A Menke
- Department of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands
| | - Vinodh Narayanan
- Translational Genomic Research Institute, Center for Rare Childhood Disorders, Phoenix, Arizona, USA
| | - Damara Ortiz
- Medical Genetics Department, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pensylvania, USA
| | - Eline Overwater
- Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Renata Posmyk
- Department of Clinical Genetics, Podlaskie Medical Center, Bialystok, Poland
| | - Keri Ramsey
- Translational Genomic Research Institute, Center for Rare Childhood Disorders, Phoenix, Arizona, USA
| | - Alessandro Rossi
- Department of Translational Medical Science, Federico II University, Naples, Italy
| | | | - Constance Stumpel
- Department of Clinical Genetics and GROW School for Oncology and Developmental Biology, Maastricht UMC, Maastricht, The Netherlands
| | - Kyra E Stuurman
- Department of Clinical Genetics Erasmus Medical Center, Rotterdam, The Netherlands
| | - Viviana Cordeddu
- Department of Hematology, Oncology and Molecular Medicine, National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy
| | - Peter Turnpenny
- Clinical Genetics Department, Royal Devon & Exeter Healthcare NHS, Exeter, UK
| | - Pietro Strisciuglio
- Department of Translational Medical Science, Federico II University, Naples, Italy
| | - Marco Tartaglia
- Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Rome, Italy
| | - Sheela Unger
- Division of Genetic Medicine, University of Lausanne, Lausanne, Switzerland
| | - Todd Waters
- North Florida Regional Medical Center, Gainesville, Florida, USA
| | - Clare Turnbull
- Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
| | - Raoul C Hennekam
- Department of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands
| |
Collapse
|